Global Hemorrhoids Treatment Market Grows Steadily at a CAGR of 5.5%

Hemorrhoid treatment refers to the various medical and non-medical approaches used to manage and alleviate the symptoms of hemorrhoidal disease, a condition characterized by swollen veins in the lower rectum and anus. Treatment options range from lifestyle modifications, such as dietary changes and increased fiber intake, to over-the-counter remedies, including creams, suppositories, and sitz baths. For more severe cases, minimally invasive procedures like rubber band ligation, sclerotherapy, and infrared coagulation are effective solutions. Market Dynamics Rising awareness programs for hemorrhoids treatment drive the global market Health education campaigns and awareness initiatives are playing a crucial role in promoting early diagnosis and timely treatment of hemorrhoids. As public understanding of the condition increases, so does the demand for effective and accessible treatment options. For example, in May 2024, the World Gastroenterology Organization launched its World Digestive Health Day campaign, highlighting the prevention and management of gastrointestinal disorders, including hemorrhoids. Such global initiatives significantly contribute to raising awareness and encouraging proactive healthcare. With a stronger emphasis on education and prevention, the demand for hemorrhoid treatments is expected to rise, further driving market growth. Advancement in technologies for hemorrhoid treatment creates tremendous opportunities The continuous evolution of medical technologies is creating substantial opportunities in the global hemorrhoids treatment market. Innovations in minimally invasive procedures and advanced pharmaceutical solutions are driving demand due to their enhanced efficacy and quicker recovery periods. For example, in June 2023, Citius Pharmaceuticals reported positive outcomes from its Phase 2b study of Halo-Lido (CITI-002), a novel drug for hemorrhoid treatment. The study demonstrated its effectiveness in alleviating symptoms such as pain and bleeding, highlighting its potential as an advanced treatment option. As cutting-edge technologies continue to emerge, they are transforming traditional treatment approaches, expanding patient access to effective solutions, and fueling market growth. Regional Analysis North America remains the dominant player in the global hemorrhoids treatment market, driven by a combination of factors such as a high incidence rate of hemorrhoids, advanced healthcare infrastructure, and increasing demand for minimally invasive treatment options. The region benefits from substantial healthcare expenditure, heightened awareness of hemorrhoidal conditions, and a strong presence of key market players pushing for innovation in treatment solutions. Moreover, favorable reimbursement policies, along with a growing number of outpatient procedures, further contribute to the market's expansion. Key Highlights The global hemorrhoids treatment market was valued at USD 1.11 billion in 2024. It is estimated to reach USD 1.82 billion by 2033, growing at a CAGR of 5.5% during the forecast period (2025–2033). Based on type, the global hemorrhoids treatment market is segmented into internal, external, and prolapsed. The internal segment is the largest revenue contributor to the market. Based on treatment, the global market is segmented into surgical intervention and pharmacological treatment. The surgical intervention segment is the largest revenue contributor to the market. Based on end users, the global hemorrhoids treatment market is segmented into hospitals and outpatient facilities. The hospital segment is the largest revenue contributor to the market. Abbott Citius Pharmaceuticals Inc. Medfiniti Servier Malaysia AstraZeneca Bayer AG Boehringer Ingelheim International GmbH Boston Scientific Corporation CONMED Corporation Pfizer Inc. Novartis AG Takeda Pharmaceutical Company Limited In March 2024, The American Society of Colon and Rectal Surgeons (ASCRS) updated its clinical practice guidelines for managing hemorrhoids. These guidelines provide healthcare professionals with the latest recommendations on diagnosis, treatment options, and patient care strategies, ensuring that patients receive evidence-based and effective treatments. By Type Internal External Prolapsed By Treatment  Surgical Intervention  Rubber band ligation  Sclerotherapy  Infrared coagulation  Hemorrhoidectomy  Hemorrhoid stapling  Others Pharmacological Treatment By End-User Hospitals Outpatient facilities By Regions North America Europe Asia-Pacific Central & South America The Middle East and Africa